XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS CHANGES IN STOCKHOLDER'S EQUITY - USD ($)
Total
Conversion of Series D preferred stock to Class A
Conversion of Series C preferred stock to Class A
Total Stockholders’ Equity
Total Stockholders’ Equity
Conversion of Series D preferred stock to Class A
Total Stockholders’ Equity
Conversion of Series C preferred stock to Class A
Additional Paid-in Capital
Additional Paid-in Capital
Conversion of Series B Preferred Stock to Class A Common Stock
Additional Paid-in Capital
Conversion of Series D preferred stock to Class A
Additional Paid-in Capital
Conversion of Series C preferred stock to Class A
Accumulated Deficit
Noncontrolling Interest
Series B Preferred Stock
Series B Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Conversion of Series B Preferred Stock to Class A Common Stock
Class A Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Common Stock
Conversion of Class B Common Stock to Class A Common Stock
Class A Common Stock
Common Stock
Conversion of Series B Preferred Stock to Class A Common Stock
Class A Common Stock
Common Stock
Conversion of Series D preferred stock to Class A
Class A Common Stock
Common Stock
Conversion of Series C preferred stock to Class A
Class A Common Stock
Common Stock
Conversion of Class C Common Stock to Class A Common Stock
Class B Common Stock
Class B Common Stock
Common Stock
Class B Common Stock
Common Stock
Conversion of Class B Common Stock to Class A Common Stock
Class C Common Stock
Class C Common Stock
Common Stock
Class C Common Stock
Common Stock
Conversion of Class C Common Stock to Class A Common Stock
Beginning balance (in shares) at Dec. 31, 2021 [1]                           5                            
Beginning balance (in shares) at Dec. 31, 2021 [1]                                 20,224,938             1,068,512     1,562,635  
Beginning balance at Dec. 31, 2021 [1] $ 71,491,476     $ 71,491,475     $ 130,348,267       $ (58,859,082) $ 0   $ 5     $ 2,022             $ 107     $ 156  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Conversion of convertible securities (in shares) [1]                                       7,989 1,031              
Conversion of convertible securities [1]   $ 365,464 $ 34,622   $ 365,464 $ 34,622     $ 365,463 $ 34,622                   $ 1                
Issuance of shares of common stock for compensation (in shares) [1]                                 4,924                      
Issuance of shares of common stock for compensation [1] 99,248     99,248     99,248                                          
Share-based compensation expense [1] 93,197     93,197     93,197                                          
Net loss [1] (3,999,560)     (3,999,560)             (3,999,560)                                  
Ending balance (in shares) at Mar. 31, 2022 [1]                           5                            
Ending balance (in shares) at Mar. 31, 2022 [1]                                 20,238,882             1,068,512     1,562,635  
Ending balance at Mar. 31, 2022 [1] 68,084,447     68,084,446     130,940,797       (62,858,642)   $ 5     $ 2,023             $ 107     $ 156  
Beginning balance (in shares) at Dec. 31, 2021 [1]                           5                            
Beginning balance (in shares) at Dec. 31, 2021 [1]                                 20,224,938             1,068,512     1,562,635  
Beginning balance at Dec. 31, 2021 [1] 71,491,476     71,491,475     130,348,267       (58,859,082) 0   $ 5     $ 2,022             $ 107     $ 156  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Net loss attributable to non-controlling interest 0                                                      
Net loss (7,224,124)                                                      
Ending balance (in shares) at Sep. 30, 2022 [1]                           5                            
Ending balance (in shares) at Sep. 30, 2022 [1]                                 22,274,897             1,068,512     1,557,947  
Ending balance at Sep. 30, 2022 [1] 75,458,890     75,458,889     141,539,601       (66,083,206)   $ 5     $ 2,226             $ 107     $ 156  
Beginning balance (in shares) at Mar. 31, 2022 [1]                           5                            
Beginning balance (in shares) at Mar. 31, 2022 [1]                                 20,238,882             1,068,512     1,562,635  
Beginning balance at Mar. 31, 2022 [1] 68,084,447     68,084,446     130,940,797       (62,858,642)   $ 5     $ 2,023             $ 107     $ 156  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Issuance of shares of common stock for compensation (in shares) [1]                                 21,482                      
Issuance of shares of common stock for compensation [1] 132,309     132,309     132,307                   $ 2                      
Shares issued from ATM (in shares) [1]                                 9,515                      
Shares issued from ATM [1] 55,137     55,137     55,136                   $ 1                      
Share-based compensation expense [1] 172,183     172,183     172,183                                          
Net loss [1] 1,539,806     1,539,806             1,539,806                                  
Ending balance (in shares) at Jun. 30, 2022 [1]                           5                            
Ending balance (in shares) at Jun. 30, 2022 [1]                                 20,269,879             1,068,512     1,562,635  
Ending balance at Jun. 30, 2022 [1] 69,983,882     69,983,881     131,300,423       (61,318,836)   $ 5     $ 2,026             $ 107     $ 156  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Exchange of shares of common stock for compensation (in shares) [1]                                 4,688                   (4,688)  
Exchange of shares of common stock for compensation [1] 0                                                      
Issuance of shares of common stock for cash, net of offering costs (in shares) [1]                                 1,811,595                      
Issuance of shares of common stock for cash, net of offering costs [1] 9,173,733     9,173,733     9,173,552                   $ 181                      
Shares issued from ATM (in shares) [1]                                 188,735                      
Shares issued from ATM [1] 1,042,186     1,042,186     1,042,167                   $ 19                      
Share-based compensation expense [1] 23,459     23,459     23,459                                          
Net loss attributable to non-controlling interest 0                                                      
Net loss [1] (4,764,370)     (4,764,370)             (4,764,370)                                  
Ending balance (in shares) at Sep. 30, 2022 [1]                           5                            
Ending balance (in shares) at Sep. 30, 2022 [1]                                 22,274,897             1,068,512     1,557,947  
Ending balance at Sep. 30, 2022 [1] 75,458,890     75,458,889     141,539,601       (66,083,206)   $ 5     $ 2,226             $ 107     $ 156  
Beginning balance (in shares) at Dec. 31, 2022                         5 5 [1]                            
Beginning balance (in shares) at Dec. 31, 2022                               22,303,333 22,303,333 [1]           1,068,512 1,068,512 [1]   1,529,888 1,529,888 [1]  
Beginning balance at Dec. 31, 2022 [1] 69,992,021     69,992,021     141,723,921       (71,734,395) 0   $ 5     $ 2,230             $ 107     $ 153  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Conversion of convertible securities (in shares) [1]                                 1,428                   (1,428)  
Series B Preferred Share removal (in shares) [1]                           (1)                            
Series B Preferred Share removal [1] 0           1             $ (1)                            
Share-based compensation expense [1] 182,589     182,589     182,589                                          
Net loss [1] (5,769,143)     (5,769,143)             (5,769,143)                                  
Ending balance (in shares) at Mar. 31, 2023 [1]                           4                            
Ending balance (in shares) at Mar. 31, 2023 [1]                                 22,304,761             1,068,512     1,528,460  
Ending balance at Mar. 31, 2023 [1] 64,405,467     64,405,467     141,906,511       (77,503,538) 0   $ 4     $ 2,230             $ 107     $ 153  
Beginning balance (in shares) at Dec. 31, 2022                         5 5 [1]                            
Beginning balance (in shares) at Dec. 31, 2022                               22,303,333 22,303,333 [1]           1,068,512 1,068,512 [1]   1,529,888 1,529,888 [1]  
Beginning balance at Dec. 31, 2022 [1] 69,992,021     69,992,021     141,723,921       (71,734,395) 0   $ 5     $ 2,230             $ 107     $ 153  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Net loss attributable to non-controlling interest (238,279)                                                      
Net loss (51,038,858)                                                      
Ending balance (in shares) at Sep. 30, 2023                         3 3 [1]                            
Ending balance (in shares) at Sep. 30, 2023                               24,331,406 24,331,406 [1]           906,012 906,012 [1]   1,501,840 1,501,840 [1]  
Ending balance at Sep. 30, 2023 20,586,831 [2]     20,825,110 [1]     143,595,686 [1]       (122,773,253) [1] (238,279) [1]   $ 3 [1]     $ 2,432 [1]             $ 91 [1]     $ 151 [1]  
Beginning balance (in shares) at Mar. 31, 2023 [1]                           4                            
Beginning balance (in shares) at Mar. 31, 2023 [1]                                 22,304,761             1,068,512     1,528,460  
Beginning balance at Mar. 31, 2023 [1] 64,405,467     64,405,467     141,906,511       (77,503,538) 0   $ 4     $ 2,230             $ 107     $ 153  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Conversion of convertible securities (in shares) [1]                             (1)   1,477,400 162,500 1           (162,500)      
Conversion of convertible securities [1] 1,000,809     1,000,809     1,000,661 $ 1             $ (1)   $ 148 $ 16             $ (16)      
Adjustment for additional shares issued in connection with the reverse stock split (in shares) [1]                                 29,995                   73  
Adjustment for additional shares issued in connection with the reverse stock split [1] 3     3                         $ 3                      
Share-based compensation expense [1] 165,289     165,289     165,289                                          
Net loss [1] (4,551,866)     (4,551,866)             (4,551,866)                                  
Ending balance (in shares) at Jun. 30, 2023 [1]                           3                            
Ending balance (in shares) at Jun. 30, 2023 [1]                                 23,974,657             906,012     1,528,533  
Ending balance at Jun. 30, 2023 [1] 61,019,702     61,019,702     143,072,462       (82,055,404)   $ 3     $ 2,397             $ 91     $ 153  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Conversion of convertible securities (in shares) [1]                                           26,749           (26,749)
Conversion of convertible securities [1]                                           $ 2           $ (2)
Adjustment for additional shares issued in connection with the reverse stock split (in shares) [1]                                                     56  
Issuance of shares of common stock for compensation (in shares) [1]                                 80,000                      
Issuance of shares of common stock for compensation [1] 91,200     91,200     91,192                   $ 8                      
Issuance of shares of common stock for cash, net of offering costs (in shares) [1]                                 250,000                      
Issuance of shares of common stock for cash, net of offering costs [1] 497,500     497,500     497,475                   $ 25                      
Share-based compensation expense [1] (65,443)     (65,443)     (65,443)                                          
Net loss attributable to non-controlling interest [1] (88,520)                     (88,520)                                
Prior period NCI [1] 0     149,759             149,759 (149,759)                                
Net loss [1] (40,867,608)     (40,867,608)             (40,867,608)                                  
Ending balance (in shares) at Sep. 30, 2023                         3 3 [1]                            
Ending balance (in shares) at Sep. 30, 2023                               24,331,406 24,331,406 [1]           906,012 906,012 [1]   1,501,840 1,501,840 [1]  
Ending balance at Sep. 30, 2023 $ 20,586,831 [2]     $ 20,825,110 [1]     $ 143,595,686 [1]       $ (122,773,253) [1] $ (238,279) [1]   $ 3 [1]     $ 2,432 [1]             $ 91 [1]     $ 151 [1]  
[1] Current and prior period results have been adjusted to reflect the one-for-eight stock split effected in May 2023. See Note 7, Stockholders' Equity for details.
[2] Current and prior period results have been adjusted to reflect the one-for-eight stock split effected in May 2023. See Note 7, Stockholders' Equity for details.